MIR1231: A Drug Target / Disease Biomarker (G100302158)
MIR1231: A Drug Target / Disease Biomarker
MIR1231, also known as interleukin-1231, is a protein that is expressed in various tissues throughout the body. It is a cytokine that plays a crucial role in the immune response and inflammation. MIR1231 has been identified as a potential drug target and a biomarker for various diseases, including cancer, autoimmune disorders, and inflammatory diseases.
MIR1231 is a cytokine that is expressed in various tissues throughout the body, including the brain, spleen, liver, and pancreas. It is a single transmembrane protein that contains a cytoplasmic tail and a N-terminus that is involved in its cytokine activity. MIR1231 is a potent cytokine that can induce various cytokine responses in cell culture and animal models.
One of the key functions of MIR1231 is its ability to stimulate the production of cytokines. Cytokines are small proteins that are secreted by cells in response to specific stimuli, such as pathogens or tissue injury. Cytokines play a crucial role in the immune response and inflammation. MIR1231 can stimulate the production of various cytokines, including interleukin-2 (IL-2), interleukin-3 (IL-3), and interleukin-10 (IL-10).
MIR1231 has also been shown to play a role in the regulation of inflammation. It can stimulate the production of pro-inflammatory cytokines, such as TNF-alpha, IL-1, and IL-6. MIR1231 can also inhibit the production of anti-inflammatory cytokines, such as IL-10. This suggests that MIR1231 may have potential as a therapeutic agent for diseases that are characterized by chronic inflammation, such as cancer, autoimmune disorders, and inflammatory diseases.
In addition to its role in the immune response and inflammation, MIR1231 has also been shown to play a role in the regulation of cell survival. It can induce cell death, either through the production of pro-apoptotic cytokines or by activating caspases and leading to the formation of apoptotic cells. MIR1231 can also stimulate the production of anti-apoptotic cytokines, such as Bcl-2, which may help to protect cells from cell death.
MIR1231 has been identified as a potential drug target for various diseases, including cancer, autoimmune disorders, and inflammatory diseases. For example, MIR1231 has been shown to be overexpressed in various cancer tissues and has been shown to promote the growth and survival of cancer cells. It has also been shown to play a role in the regulation of immune cell function, and may be a potential therapeutic target for autoimmune disorders. Additionally, MIR1231 has been shown to be involved in the regulation of inflammation, and may be a potential therapeutic target for inflammatory diseases.
In conclusion, MIR1231 is a protein that is expressed in various tissues throughout the body and plays a crucial role in the immune response and inflammation. Its ability to stimulate the production of cytokines and its role in the regulation of inflammation make it a potential drug target for various diseases, including cancer, autoimmune disorders, and inflammatory diseases. Further research is needed to fully understand the role of MIR1231 in these diseases and to develop safe and effective therapies that target this protein.
Protein Name: MicroRNA 1231
The "MIR1231 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1231 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR1233-1 | MIR1233-2 | MIR1234 | MIR1236 | MIR1237 | MIR1238 | MIR124-1 | MIR124-1HG | MIR124-2 | MIR124-2HG | MIR124-3 | MIR1243 | MIR1244-1 | MIR1244-2 | MIR1244-3 | MIR1245A | MIR1245B | MIR1246 | MIR1247 | MIR1248 | MIR1249 | MIR1250 | MIR1251 | MIR1252 | MIR1253 | MIR1254 | MIR1255A | MIR1255B1 | MIR1255B2 | MIR1256 | MIR1257 | MIR1258 | MIR125A | MIR125B1 | MIR125B2 | MIR126 | MIR1260A | MIR1260B | MIR1261 | MIR1262 | MIR1263 | MIR1264 | MIR1265 | MIR1266 | MIR1267 | MIR1268A | MIR1268B | MIR1269A | MIR1269B | MIR127 | MIR1270 | MIR1271 | MIR1272 | MIR1273A | MIR1273C | MIR1273H | MIR1275 | MIR1276 | MIR1277 | MIR1278 | MIR1279 | MIR128-1 | MIR128-2 | MIR1280 | MIR1281 | MIR1282 | MIR1283-1 | MIR1283-2 | MIR1284 | MIR1285-1 | MIR1285-2 | MIR1286 | MIR1287 | MIR1288 | MIR1289-1 | MIR1289-2 | MIR129-1 | MIR129-2 | MIR1290 | MIR1291 | MIR1292 | MIR1293 | MIR1294 | MIR1295A | MIR1295B | MIR1296 | MIR1297 | MIR1298 | MIR1299 | MIR1301 | MIR1302-1 | MIR1302-10 | MIR1302-11 | MIR1302-2 | MIR1302-3 | MIR1302-4 | MIR1302-5 | MIR1302-6 | MIR1302-7 | MIR1302-8
